Effects of Large Extracellular Vesicles from Kidney Cancer Patients on the Growth and Environment of Renal Cell Carcinoma Xenografts in a Mouse Model

被引:0
|
作者
Ferragu, Matthieu [1 ]
Vergori, Luisa [2 ]
Le Corre, Vincent [1 ]
Bellal, Sarah [3 ]
Martinez, Maria del Carmen [2 ,4 ]
Bigot, Pierre [1 ]
机构
[1] Angers Univ Hosp, Urol Dept, F-49100 Angers, France
[2] INSERM, UMR 1063, Stress Oxydant & Pathol Metab, F-49100 Angers, France
[3] Angers Univ Hosp, Anatomopathol Dept, F-49100 Angers, France
[4] Univ Montpellier, PhyMedExp, INSERM, CNRS,UMR, F-34090 Montpellier, France
关键词
cancer; renal cancer; large extracellular vesicle; tumor growth; angiogenesis; peritumoral environment; xenograft; mouse model; EXOSOMES; ANGIOGENESIS; ESTABLISHMENT; MECHANISMS; PHENOTYPE; DIAGNOSIS; SURVIVAL;
D O I
10.3390/cimb45030163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma membrane-derived vesicles, also referred to as large extracellular vesicles (lEVs), are implicated in several pathophysiological situations, including cancer. However, to date, no studies have evaluated the effects of lEVs isolated from patients with renal cancer on the development of their tumors. In this study, we investigated the effects of three types of lEVs on the growth and peritumoral environment of xenograft clear cell renal cell carcinoma in a mouse model. Xenograft cancer cells were derived from patients' nephrectomy specimens. Three types of lEVs were obtained from pre-nephrectomy patient blood (cEV), the supernatant of primary cancer cell culture (sEV) and from blood from individuals with no medical history of cancer (iEV). Xenograft volume was measured after nine weeks of growth. Xenografts were then removed, and the expression of CD31 and Ki67 were evaluated. We also measured the expression of MMP2 and Ca9 in the native mouse kidney. lEVs from kidney cancer patients (cEV and sEV) tend to increase the size of xenografts, a factor that is related to an increase in vascularization and tumor cell proliferation. cEV also altered organs that were distant from the xenograft. These results suggest that lEVs in cancer patients are involved in both tumor growth and cancer progression.
引用
收藏
页码:2491 / 2504
页数:14
相关论文
共 50 条
  • [21] Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease
    Ding, Hao
    Li, Linda Xiaoyan
    Harris, Peter C.
    Yang, Junwei
    Li, Xiaogang
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [22] The modulatory effects of large and small extracellular vesicles from normal human urine on calcium oxalate crystallization, growth, aggregation, adhesion on renal cells, and invasion through extracellular matrix: An in vitro study
    Hadpech, Sudarat
    Chaiyarit, Sakdithep
    Phuangkham, Somsakul
    Sukphan, Sirirat
    Thongboonkerd, Visith
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [23] Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma
    Maruoka, Hiroshi
    Tanaka, Tomohito
    Murakami, Hikaru
    Tsuchihashi, Hiromitsu
    Toji, Akihiko
    Nunode, Misa
    Daimon, Atsushi
    Miyamoto, Shunsuke
    Nishie, Ruri
    Ueda, Shoko
    Hashida, Sousuke
    Terada, Shinichi
    Konishi, Hiromi
    Kogata, Yuhei
    Taniguchi, Kohei
    Komura, Kazumasa
    Ohmichi, Masahide
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [24] Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma
    Dourado, Mauricio Rocha
    Korvala, Johanna
    Astrom, Pirjo
    De Oliveira, Carine Ervolino
    Cervigne, Nilva K.
    Mofatto, Luciana Souto
    Bastos, Debora Campanella
    Pereira Messetti, Ana Camila
    Graner, Edgard
    Paes Leme, Adriana Franco
    Coletta, Ricardo D.
    Salo, Tuula
    JOURNAL OF EXTRACELLULAR VESICLES, 2019, 8 (01):
  • [25] Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England
    Brown, Janet
    Harrow, Brooke
    Marciniak, Anne
    McCarthy, Christine
    Houchard, Aude
    Cirneanu, Lori
    Protheroe, Andrew
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (02) : 195 - 207
  • [26] Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles
    Cabiati, Manuela
    Gaggini, Melania
    De Simone, Paolo
    Salvadori, Costanza
    Del Turco, Serena
    Caselli, Chiara
    Cecchettini, Antonella
    Del Ry, Silvia
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 243
  • [27] Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients
    Procopio, Giuseppe
    Testa, Isabella
    Verzoni, Elena
    Iacovelli, Roberto
    Grassi, Paolo
    Galli, Giulia
    De Braud, Filippo
    Saravia, Diana
    Salvioni, Roberto
    ONCOLOGY, 2015, 88 (03) : 133 - 138
  • [28] Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience
    Dragomir, Alice
    Nazha, Sara
    Wood, Lori A.
    Rendon, Ricardo A.
    Finelli, Antonio
    Hansen, Aaron
    So, Alan, I
    Kollmannsberger, Christian
    Basappa, Naveen S.
    Pouliot, Frederic
    Soulieres, Denis
    Heng, Daniel Y. C.
    Kapoor, Anil
    Tanguay, Simon
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (10) : 799.e1 - 799.e10
  • [29] Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma
    Hu, Xiao-Ying
    Liu, Dong-Wei
    Qiao, Ying-Jin
    Zheng, Xuan
    Duan, Jia-Yu
    Pan, Shao-Kang
    Liu, Zhang-Sou
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11783 - 11791
  • [30] Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma
    Gu, Jun
    He, Zexi
    Huang, Yinglong
    Luan, Ting
    Chen, Zhenjie
    Wang, Jiansong
    Ding, Mingxia
    DISEASE MARKERS, 2022, 2022